30% of Tech Mahindra employees to eventually work from home permanently

Given the current uncertainty, only a small number of staff will work from offices, at least for one or two quarters.

Moneycontrol News

July 27, 2020 / 22:46 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Tech Mahindra will eventually have close to 25-30 percent of its employees work from home (WFH) permanently, said Manoj Bhat, CFO, Tech Mahindra.

Speaking to the media after the first quarter results, Bhat said, “Now more than 90 percent of people are working from home. Customers are appreciating that we have been able to meet expectations in terms of service delivery. To me, overall long term, 25-30 percent will be permanent WFH.”

“Given the current uncertainty, working from offices will be a very small number, potentially at least for one or two quarters,” he added.

In an earlier statement, the company said less than one percent of the employees are currently working out of office. Earlier, some of its service lines like business process services faced some challenges when employees worked from home.

Bhat explained that the company has made investments in the integrated command and control centre that allows it to drive outcomes and put in risk mitigation plans, be it working from home or office.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show